Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 42

2.

Does aspirin or non-aspirin non-steroidal anti-inflammatory drug use prevent colorectal cancer in inflammatory bowel disease?

Burr NE, Hull MA, Subramanian V.

World J Gastroenterol. 2016 Apr 7;22(13):3679-86. doi: 10.3748/wjg.v22.i13.3679. Review.

3.

ACG Clinical Guideline: Management of Patients With Acute Lower Gastrointestinal Bleeding.

Strate LL, Gralnek IM.

Am J Gastroenterol. 2016 Apr;111(4):459-74. doi: 10.1038/ajg.2016.41. Epub 2016 Mar 1.

4.

Risk factors for adverse in-hospital outcomes in acute colonic diverticular hemorrhage.

Nagata N, Niikura R, Aoki T, Moriyasu S, Sakurai T, Shimbo T, Sekine K, Okubo H, Watanabe K, Yokoi C, Akiyama J, Yanase M, Mizokami M, Fujimoto K, Uemura N.

World J Gastroenterol. 2015 Oct 7;21(37):10697-703. doi: 10.3748/wjg.v21.i37.10697.

5.

Structure and Inhibition of Microbiome β-Glucuronidases Essential to the Alleviation of Cancer Drug Toxicity.

Wallace BD, Roberts AB, Pollet RM, Ingle JD, Biernat KA, Pellock SJ, Venkatesh MK, Guthrie L, O'Neal SK, Robinson SJ, Dollinger M, Figueroa E, McShane SR, Cohen RD, Jin J, Frye SV, Zamboni WC, Pepe-Ranney C, Mani S, Kelly L, Redinbo MR.

Chem Biol. 2015 Sep 17;22(9):1238-49. doi: 10.1016/j.chembiol.2015.08.005. Epub 2015 Sep 10.

6.

Advances in NSAID development: evolution of diclofenac products using pharmaceutical technology.

Altman R, Bosch B, Brune K, Patrignani P, Young C.

Drugs. 2015 May;75(8):859-77. doi: 10.1007/s40265-015-0392-z. Review.

7.

Safe prescribing of non-steroidal anti-inflammatory drugs in patients with osteoarthritis--an expert consensus addressing benefits as well as gastrointestinal and cardiovascular risks.

Scarpignato C, Lanas A, Blandizzi C, Lems WF, Hermann M, Hunt RH; International NSAID Consensus Group.

BMC Med. 2015 Mar 19;13:55. doi: 10.1186/s12916-015-0285-8.

8.

Suppression of contractile activity in the small intestine by indomethacin and omeprazole.

Lichtenberger LM, Bhattarai D, Phan TM, Dial EJ, Uray K.

Am J Physiol Gastrointest Liver Physiol. 2015 May 1;308(9):G785-93. doi: 10.1152/ajpgi.00458.2014. Epub 2015 Feb 26.

9.

Gastrointestinal injury associated with NSAID use: a case study and review of risk factors and preventative strategies.

Goldstein JL, Cryer B.

Drug Healthc Patient Saf. 2015 Jan 22;7:31-41. doi: 10.2147/DHPS.S71976. eCollection 2015. Review.

10.
11.
12.

Nonsteroidal anti-inflammatory drugs and upper and lower gastrointestinal mucosal damage.

Sostres C, Gargallo CJ, Lanas A.

Arthritis Res Ther. 2013;15 Suppl 3:S3. doi: 10.1186/ar4175. Epub 2013 Jul 24. Review.

13.

Cyclo-oxygenase-2 inhibitors or nonselective NSAIDs plus gastroprotective agents: what to prescribe in daily clinical practice?

Masclee GM, Valkhoff VE, van Soest EM, Schade R, Mazzaglia G, Molokhia M, Trifirò G, Goldstein JL, Hernández-Díaz S, Kuipers EJ, Sturkenboom MC.

Aliment Pharmacol Ther. 2013 Jul;38(2):178-89. doi: 10.1111/apt.12348. Epub 2013 May 28.

14.

Greater number of narcotic analgesic prescriptions for osteoarthritis is associated with falls and fractures in elderly adults.

Rolita L, Spegman A, Tang X, Cronstein BN.

J Am Geriatr Soc. 2013 Mar;61(3):335-40. doi: 10.1111/jgs.12148. Epub 2013 Mar 1.

15.

Mucosal healing effect of mesalazine granules in naproxen-induced small bowel enteropathy.

Rácz I, Szalai M, Kovács V, Regőczi H, Kiss G, Horváth Z.

World J Gastroenterol. 2013 Feb 14;19(6):889-96. doi: 10.3748/wjg.v19.i6.889.

17.

Increased incidence and impact of upper and lower gastrointestinal events in patients with rheumatoid arthritis in Olmsted County, Minnesota: a longitudinal population-based study.

Myasoedova E, Matteson EL, Talley NJ, Crowson CS.

J Rheumatol. 2012 Jul;39(7):1355-62. doi: 10.3899/jrheum.111311. Epub 2012 Apr 1.

18.

Managing pain in inflammatory bowel disease.

Docherty MJ, Jones RC 3rd, Wallace MS.

Gastroenterol Hepatol (N Y). 2011 Sep;7(9):592-601.

19.

A turbulent decade for NSAIDs: update on current concepts of classification, epidemiology, comparative efficacy, and toxicity.

Conaghan PG.

Rheumatol Int. 2012 Jun;32(6):1491-502. doi: 10.1007/s00296-011-2263-6. Epub 2011 Dec 23. Review.

20.

Validation of ICD-9-CM codes to identify gastrointestinal perforation events in administrative claims data among hospitalized rheumatoid arthritis patients.

Curtis JR, Chen SY, Werther W, John A, Johnson DA.

Pharmacoepidemiol Drug Saf. 2011 Nov;20(11):1150-8. doi: 10.1002/pds.2215. Epub 2011 Aug 27.

Supplemental Content

Support Center